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Summary 
We have previously produced a transgenic mouse line for hen egg lysozyme (HEL), an experimental 
model for analyzing tolerance to self-antigens at the peptide level. We have now characterized 
transgenic mice with HEL blood levels below 2 ng/ml, where significant T  cell proliferative 
responses to HEL and its immunodominant peptide were observed. This HEL-low transgenic 
model was chosen because it mimics physiological conditions in which autoreactive T lymphocytes, 
recognizing self-components expressed at very low levels, persist without inducing a break in 
tolerance. Furthermore, in H-2  d mice, HEL-specific T  lymphocytes are triggered by a single 
immunodominant region, allowing us to compare the HEL-specific T  cell VB repertoires of 
transgenic and nontransgenic animals against a single peptide presented as self or foreign, respectively. 
We found that a V/38.2-D/31-J/31.5 rearrangement is found in response to HEL in all nontransgenic 
mice, whereas this V/3-restricted response is absent in HEL-low transgenic animals. At the nucleotide 
level, this rearrangement results from the trimming of the genomic segments during VDJ or 
DJjoining, without N  additions, suggesting that the dominant rearrangement is selected early 
during fetal or neonatal life, before the expression of terminal deoxynucleotidyl transferase.  In 
HEL-low transgenic mice, no dominant rearrangements are found as alternatives to the one observed 
in normal mice. Instead, each transgenic animal uses a different set of V~-J/3 combinations in 
its response to the immunodominant HEL peptide. In nontransgenic mice, besides the dominant 
VB8.2-D/31-J~l.5 combination, minor VB repertoires were found which differed in each animal 
and were distinct from the rearrangements used by individual transgenic mice. These findings 
suggest that the T cell response to an immunodominant peptide involves a "public" V/5 repertoire 
found in all animals and a "private" one which is specific to each individual. 
T 
he ot/B TCR for antigen is a heterodimeric disulphide- 
linked membrane glycoprotein that specifically interacts 
with peptides bound to MHC molecules. It is composed of 
two polypeptide chains with variable (Vc~ and V/3) and con- 
stant (Ccr and C/3) domains (1). The variable domains result 
from the somatic recombination of V  and J  gene segments 
for Vot and V, D, andJ gene segments for V/3. The diversity 
generated by these rearrangements is increased by imprecise 
joining of the various gene segments and addition of template- 
independent N  nucleotides during this process (2). 
T cell responses are induced by foreign antigens presented 
as peptides in the context of self-MHC molecules (3). A syn- 
thetic peptide can mimick a foreign antigen if it has the same 
amino acid sequence as the native epitope presented by MHC 
molecules (4, 5). It is now well established that foreign an- 
tigens as well as self-proteins are processed into peptides, which 
are loaded and presented by MHC molecules (6-11).  Studies 
on TcR repertoires have shown that the Vot-Jot and vB-JB 
rearrangements, from antigen-specific TcRs, are selected by 
MHC-restricted antigenic peptides (12-15).  In the thymus, 
immature lymphocytes go through complex steps of differen- 
tiation and selection that eliminate self-reactive cells and stimu- 
late those that can recognize foreign peptides in the context 
of self-MHC (16-20). 
Not all self-reactive T  cells are eliminated. Autoreactive 
T  cell responses have been reported in models of central as 
weU as peripheral tolerance (21-27). Normally, self-proteins 
are processed in the thymic APCs in such a way that only 
self-peptides bound to MHC molecules in sufficient amounts 
can tolerize specific T lymphocytes. However, subdominant 
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ments that are not produced by APCs as efficiently as im- 
munodominant (ID) peptides (for a review on dominance 
and crypticity, see Sercarz et al.  [28]). In transgenic mouse 
models  of peripheral  tolerance,  extrathymic  self-peptides 
presented by nonprofessional APCs lacking the appropriate 
accessory molecules can either be ignored by specific T lym- 
phocytes (26) or lead to different states ofanergy of autoreac- 
tire T  cells (27). But these self-reactive T  cells can be acti- 
vated and induce specific  tissue destruction (27). 
We have previously studied, in a mouse transgenic line for 
hen egg lysozyme (HEL), the state of tolerance to HEL and 
various peptides derived from it (24). We have found that 
H-2  d transgenic mice were tolerant to HEL and its  single 
immunodominant determinant. However, the state of toler- 
ance to SD peptides 1-18 and 74-96 was highly dependent 
on HEL blood concentrations in transgenic animals. Autoreac- 
tire T lymphocytes specific for these SD peptides were inac- 
tivated as HEL serum level increased (24). Furthermore, HEL 
transgenic  mice with  HEL blood concentrations below 2 
ng/ml (HEL-low transgenic mice) respond to HEL and to 
the ID 15-mer peptide 103-117 (29). It is interesting to note 
that the minimal ID peptide 108-116, which induces repro- 
ducible T cell proliferative responses in nontransgenic mice, 
does not elicit any response in most of the HEL-low trans- 
genic mice tested. This suggests that, in these transgenic mice, 
the HEL-specific TcR repertoire has been negatively selected 
only partially since in vitro responses to the 15-mer ID pep- 
tide are still obtained. In another transgenic mouse model, 
human insulin is expressed at serum levels below 0.2 ng/ml 
and specific T cell proliferative responses are recalled in vitro 
by the human  hormone (23). 
Since  HEL-specific  T  lymphocytes  in  H-2  a  mice  are 
stimulated by only one ID region, we could compare the 
HEL-specific T  cell VI3 repertoires of transgenic and non- 
transgenic animals against a single determinant presented as 
a self or as a foreign peptide, respectively. Using a new meth- 
odology described by Pannetier et al.  (30), we studied the 
TcR V3 repertoires of HEL-specific T  lymphocytes in in- 
dividual mice. We found that the most frequently selected 
TcR V3 rearrangement: V38.2-D31-J31.5, is observed in all 
nontransgenic mice, whereas it is lacking in HEL-Iow trans- 
genic mice. The V/8 repertoire in HEL-low transgenic mice 
is striking,  since each animal uses  a different set of VB-J3 
rearrangement in its response to HEL or peptide 103-117. 
No dominant rearrangement is found as an alternative to the 
one observed in normal mice. Moreover, in nontransgenic 
mice, the minor V3 repertoires found in addition to the dom- 
inant V/B8.2-D~l-J~l.5 are also different in each animal. These 
findings  indicate  that  each  HEL-low  transgenic  mouse 
responds to peptide 103-117 with its own repertoire of V/~- 
J~Ss; in normal mice, there is a highly V/~-restricted response 
1Abbreviations  used in  this paper: HEL, hen  egg  lysozyme; ID, 
immunodominant; LNC, lymph node cell; RIS, relative index of 
stimulation; SD, subdominant. 
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to the antigen with a predominant V/38.2-D/31-fll.5 rear- 
rangement, whereas the minor combinations are different in 
each mouse and may correspond to the only response seen 
in the transgenic mice. 
Materials  and Methods 
Mice.  Transgenic  mice for HEL have been described elsewhere 
(24). Transgenic mice, nontransgenic littermates, and control mice 
(BALB/c, H-2  d) were bred and maintained at the Centre de Ser- 
vice et d'Elevage des Animaux  de Laboratoire (CSEAL) (Centre 
National de la Recherche Scientifique, Orleans, France) in specific 
pathogen-free conditions. A standard PCR assay with HEL primers 
was used as a fast screen for transgenic mice. HEL serum concen- 
tration in transgenic mice was measured by an ELISA assay as de- 
scribed previously (24). 
Proliferation  Assay.  Transgenic  and control mice were immunized 
in the hind footpads with 3.5 nmol of HEL in CFA. 9 d later, 
popliteal lymph nodes were collected, and lymph node cells (LNC) 
were cultured at 5  x  105 cells per well with different concentra- 
tions of HEL or 15-mer 103-117 peptide and 5% CO2 for 4 d. All 
cultures were done in HL-1 medium (Ventrex Laboratories, Port- 
land, ME) supplemented with glutamine (2 mM). Then, stimu- 
lated cells were collected in order to extract their mRNA or to 
produce T cell hybridomas. 
T Cell Hybridomas.  Lymphocytes stimulated 4 d in culture by 
HEL were collected and mixed with the thymoma BW5147 (TCR- 
a/~-) (31) at a 4:1 ratio in a solution  (50:50, vol/vol) of PEG 
(poly-ethylene-glycol, hybrimax, Sigma Chemical Co., St. Louis, 
MO) and RPMI 1640 medium (GIBCO BRL, Gaithersburg, MD) 
prewarmed at 37~  for 3 min.  The cells were washed once and 
resuspended in RPMI 1640 medium supplemented with glutamine 
(2 raM), 2-ME (5  x  10 -5 M), and 20% FCS (Serovial, Brumath, 
France) and cultured at a concentration of 2  x  105 cells per well 
in 96-well plates (Falcon Labware, Oxnard, CA). A solution of 
HAT was added to each well and the plates were incubated at 37~ 
in 5% CO2.1-2 wk later, T cell hybridomas were tested for their 
reactivity to HEL and ID peptide 103-117 by measuring the amount 
of IL-2 released in 24 h. This was done by the colorimetric method 
described by Mosmann (32). The cells from positive wells were 
then cloned at 0.3 cells per well. 
Oligonucleotides.  Sense  oligonuc/eotides specific  for each of the 
23 V~ chains and antisense oligonucleotides for C~ and J~ were 
synthesized  on a DNA synthesizer  (Applied  Biosystems, Foster City, 
CA). These oligonucleotides have been described elsewhere (30). 
Fluorophores were attached via an aminolink-2 at the 5' end of 
the J/3 oligonucleotide. V~33, VB5, V~311, and V/317 were not mea- 
sured since these V/3s are deleted by mouse mammary tumor virus 
(MMTV) in BALB/c mice (33). 
mRNA Extraction and eDNA Synthesis.  mRNAs from T cell 
hybridomas and lymphocytes  in culture were extracted with a Quick 
mRNA Micro Prep Kit (Pharmacia, Piscataway, NJ). Briefly, cells 
were lysed in guanidium thiocyanate and mRNAs were purified 
by affinity chromatography on oligo-dT cellulose. After ethanol 
precipitation, mRNAs were dissolved in water, aliquoted, and kept 
at  -80~  RNAs were reverse transcribed into cDNA using a 
cDNA synthesis kit (Boehringer  Mannheim, Mannheim, Germany). 
After denaturation  at 70~  for 10 min, mRNAs were incubated 
with poly-dT primers (5/zM) and 2 U of  reverse  transcriptase (from 
AMV) at 43~  for 1 h, followed by an incubation at 53~  for 
10 rain. A PCR assay was done with aldolase primers in order to 
control each cDNA preparation. 
PCR and Run-off Reactions.  For PCR, aliquots ofcDNA were 
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primers using 2 U of Taq DNA polymerase (Promega, Madison, 
WI) in the supplier buffer. 40 cycles were performed,  involving 
first a 1-min denaturation  step at 94~  a 1-min annealing step 
at 60~  and a 4-rain polymerization  step at 72~  followed by 
an elongation  step at 72~  for 10 min. For all PCKs performed, 
a negative control was included where cDNA was replaced  by water. 
PCR products  were electroeluted,  precipitated,  and dissolved in 
water before use in sequencing  or run-off reactions. 
For run-off reactions and determination of relative index of stim- 
ulation (RIS), PCR products were elongated with each of the 12 
fluorophore-labeled J3 oligonucleotides  in a five cycle PCR step 
(run-off) and loaded on a 6% acrylamide sequencing gel on a DNA 
sequencer (model 373A; Applied Biosystems). For each V3-J3 rear- 
rangement,  the fluorescent run-off products  of various sizes that 
had been elongated through the CDR3 regions were separated on 
the denaturing gel and their lengths calculated by comparison with 
appropriate size standards. In all V/3-J3 combinations, these elon- 
gation products were distributed into 6-11 peaks and corresponded 
to in-frame transcripts. For any given peak, after treatment  of the 
data by software developed in our laboratory  (30), the RIS was 
calculated using the following formula:  R.IS =  [(area of one ex- 
perimental peak)/(sum of areas of aU other experimental peaks)/(area 
of corresponding control peak)/(sum of areas of all other control 
peaks)]. This equation  can be written:  RIS  =  [(area of one ex- 
perimental peak)/(area of corresponding control peak)  x  (sum of 
areas of all other control peaks)/(sum  of areas of all other ex- 
perimental  peaks)] (1). When the peak profiles from the second 
term of the equation (1) were fitted so as to maximize the number 
of superimposed peaks, the second term is about 1. Thus,  after 
this normalization,  a simpler formula of the RIS was obtained: 
RIS =  (area of one experimental peak/area of corresponding con- 
trol peak). Therefore, an increase in R.IS for a peak of a given nucleo- 
tide length is directly proportional  to the augmentation  of KNA 
messengers corresponding to this particular V/~-J/~ rearrangement. 
Sequence of PCR Products.  PCK products  were  directly  se- 
quenced using the method described by Casanova et al. (34). Briefly, 
aliquots of PCR products were denatured by boiling at 100~  for 
10 min in the presence of a given primer and transferred quickly 
at  -70~  in dry ice and ethanol (95%). The frozen material was 
simultaneously thawed and mixed with [35S]dATP and sequenase 
(United States Biochemical Corp., Cleveland, OH) for 45 s in the 
supplier buffer. The ddNTPs were then added and the elongation 
was performed for 3 min at room temperature.  The material was 
then loaded on a 6% acrylamide sequencing gel. Autoradiography 
of the dried gel was performed at room temperature with Kodak 
films. 
Results 
Choice of the Transgenic  Animals and of the HEL Peptide.  We 
have previously produced a HEL transgenic  mouse line by 
microinjecting (BALB/c  x  DBA/2)  x  BALB/c eggs (H-2  d 
haplotype) with a HEL cDNA placed under the control of 
the ubiquitously expressed housekeeping gene promoter, the 
mouse hydroxymethyl glutaryl Co-A reductase (24). The trans- 
genic line was derived from one female founder subsequently 
backcrossed to BALB/c males. The repertoire studies presented 
here  were  performed  with  transgenic  and  nontransgenic 
animals  from  crosses between HEL  transgenic  males  and 
BALB/c females, in order to  avoid a potential  tolerization 
of nontransgenic littermates by transplacental influx of HEL 
from their transgenic mother. Such a maternal effect has been 
observed previously in nontransgenic mice born from females 
transgenic  for the  secreted hepatitis  Be antigen  (35). 
HEL transgenic mice express different amounts of HEL, 
even in the same litter, but in a given individual, HEL blood 
level variations do not exceed _+ 30%. These features of the 
HEL transgenic  line have allowed us to study the  state of 
tolerance to HEL in transgenic  animals  over a broad range 
of HEL blood concentrations (0.5-1,500 ng/ml). Our previous 
results have shown that mice expressing >10 ng/ml are fully 
tolerant to HEL. However, mice expressing <2 ng/ml often 
display T cell proliferative responses when immunized with 
HEL (29). These HEL-low transgenic mice were further ana- 
lyzed with HEL peptides in in vitro recall experiments: LNC 
from HEL-low animals immunized with HEL in CFA were 
incubated with various HEL peptides. The 15-mer ID pep- 
tide 103-117 triggered only a proliferative response, whereas 
the 9-met ID peptide 108-116 and SD peptides 1-18 and 74- 
96 had no effect. Nontransgenic  BALB/c mice respond  to 
both ID peptides 108-116 and 103-117. Hence, we could ana- 
lyze and compare the T cell responses to the ID 103-117 pep- 
tide in BALB/c nontransgenic mice and in partially tolerant 
HEL-low transgenic mice. For a variety of reasons discussed 
below, our analysis was focused on the/3 chains of TcR reacting 
with  the ID  103-117  peptide. 
Analysis of a Hybridoma Collection.  We had previously de- 
scribed a collection of 14 T cell hybridomas that respond to 
HEL and to the 103-117  peptide (29).  These were isolated 
from HEL-primed LNC of BALB/c mice triggered in vitro 
by HEL for 4 d. As a first approach to our repertoire analysis, 
we decided to sequence the TCR. 3 chain transcripts of these 
hybridomas.  For  this,  we  extracted  RNA  from  each  hy- 
bridoma, prepared cDNA, and performed a PCR with sense 
oligonucleotides specific for each of the 23 known V3 seg- 
ments and antisense C~ oligonucleotide (30).  We then se- 
quenced the double-stranded PCR products (34). All nucleo- 
tide sequences contained open reading frames encoding TcR 
VB residues. The expression of V38.2 and V36 chains was 
confirmed by flow cytometry analysis  of the T  cell hybrid- 
omas after staining with the corresponding anti-V3 mAbs 
(data not shown). The V38.2 gene segment is expressed in 
12 out of 14 T cell hybridomas (Fig. 1). Among the 12 V38.2 
T  cell hybridomas, 6 different JB segments were rearranged 
0B1.1, J31.4, JB1.6, J32.1, J32.3, and J~2.4).  Four CDR3 
of different lengths (8, 9, 10, and 13 amino acids), as defined 
by Chothia et al. (36), were observed. Although the 12 TCR 
V3 junctional regions were very diverse in terms of J~ seg- 
ment usage and CDR.3 length,  four amino acid residues of 
the CDR3 loop were highly conserved: G95, T96, G97, and 
N98 (Fig.  2). Furthermore,  Q98, a residue mostly encoded 
in the N  diversity region, is a close homologue of N98 and 
is found in four independent T cell hybridomas. Finally, C6.2 
and M3.13, two independent hybridomas using V/38.2, D31, 
and JB1.5 segments, displayed an identical CDR3 sequence: 
G95 T96 G97 N98 N99 Q100 A101 P102. 
These results provide a useful database but,  in terms of 
863  Cibotti et al. HYB ￿9  T 
v~  P  N  v  D~ 
e. 2 s  s.2  ~CCAGC  GATAC  C.C~C 
B  11 ￿9  1  8.2  TGTGCCAGCGG  GA  C  GGGACA 
B  9 .  1  8.2  TGTGCCAGCGGT  ACAGGG 
C  6 .  2  8.2  TGTGCCAGC  GGGACAGGG 
M  3 .  13  8  .  2  TGTGCCAGC  GGGACAGGG 
C  11 .  3  8  .  2  TGTGCCAGC  GGGACAGGG 
D  3 .  5  8  .  2  TGTGCCAG  A  GGGACq~GGG 
C  9 .  1  8.2  TGTGCCAGC  GGGACAGGG 
B  4 .  2  8  .  2  TGTGCCAGCGGT  ACAGGG 
B  10 ￿9  2  8.2  TGTGCCAGC  GGGACAGGG 
B  5.1  8.2  TGTGCCAGCGGT  T  C  GGGACAGGGGGC 
e  8  .  10  8.2  TGTGCCAGCGGTGATG  C  GA  GGACTC.GC~GGGC 
e  5 ￿9 4  6  TGTGCCAGCAGTA  T  CA  GGACA 
DI2.8  6  TGTGCCAGCAGTA  TA  CGC  CAG 
Figure  1. 
N 
CAAT 
AG 
AACAACCGACTG 
AACG 
CAGG 
AATGGAAAT 
P  J~ 
CAAACACAGAAGTCTTCTTTGGT 1  .  1 
CCAACGAAAGATTATTTTTCGGT 1  ￿9  4 
CCGCTTTTTGGA  1.5 
AACAACCAGGCTCCGCTTTTTGGA 1  ￿9 5 
AACAACCAGGCTCCGCTTTTTGGA 1.5 
ATAATTCGCCCCTCTACTTTGCG  1  .  6 
AACTATGCTGAGCAGTTCTTCGGA 2  .  1 
GTGCAGAAACGCTGTATTTTGGC 2.3 
GTGCAGAAACGCTGTATTTTGGC 2  .  3 
ACGCTGTATTTTGGC  2.3 
AGAAACGCTGTATTTTGGC 2  .  3 
T  AGTCAAAACACCTTGTAC TTGGT  2  .  4 
AA TTCTGGAAATACGCTCTA~A  1.3 
CAAGACACCCAGTACTTTGGG 2  .  5 
Nucleotide sequences of V~8 chains from HEL specific T cell hybridomas. RNAs from T cell hybridomas were extracted and reverse tran- 
scribed as described in Materials and Methods.  cDNAs were amplified with sense V~8.2 or V~6 and with antisense C~/primers.  Amplified products 
were sequenced as described by Casanova et al. (34). Underlined sequences correspond to nucleotides of D~82 origin.  These sequence data are available 
from EMBL/GenBank/DDBJ under accession number X79950-X79963. 
repertoire analysis, the hybridoma approach suffers severe limi- 
tations: it is quite labor intensive, and it is difficult to isolate 
hybridomas in large enough numbers that would make an 
analysis  of the minor responses statistically significant.  Fur- 
thermore, the distribution of TCR sequences in hybridomas 
might not reflect  accurately the in vivo situation. We, there- 
HYB. T  V~  Fw  CDR3  Fw 
G8.25  8.2  CAS  N  T  G  Q  S  N  T  E  V  FFG 
BII.I  8.2  CAS  G  T  G  Q  A  N  E  R  L  FFG 
B9.1  8.2  CAS  O  T  G  N  N  R  L  P  LFG 
C6.2  8.2  CAS  G  T  G  N  N  Q  A  P  LFG 
M3.13  8.2  CAS  G  T  G  N  N  Q  A  P  LFG 
CII.3  8.2  CAS  G  T  G  N  N  S  P  L  YFA 
D3.5  8.2  CAS  O  T  G  N  Y  A  E  Q  FFG 
C9.1  8.2  CAS  G  T  O  N  G  A  E  T  L  YFG 
B4.2  8.2  CAS  G  T  G  Q  G  A  V  T  L  YFG 
B10.2  8.2  CAS  G  T  G  N  G  N  T  L  YFG 
B5.1  8.2  CAS  O  S  O  Q  G  A  E  T  L  YFG 
C8.10  8.2  CAS  G  D  A  R  T  G  G  A  S  Q  N  T  LYFG 
C5.4  6  CAS  S  I  R  T  N  S  G  N  T  L  YFG 
D12.8  6  CAS  S  I  R  Q  Q  N  T  Q  YFG 
Figure  2.  Amino acid sequences of VB chain junctional regions from 
14 HEL-specific T cell hybridomas. (Boldface) Highly conserved residues 
corresponding to the CDR3 sequence of the dominant V/38.2 DB1 JB1.5 
rearrangement.  These  sequence  data are  available from  EMBL/Gen- 
Bank/DDBJ under accession number X79950-X79963. 
fore, turned to a PCR-based approach, which provides a global 
description of the ~  chain transcripts  and can be applied to 
individual mice. 
Distribution of TCR ,6 Chain Transcripts  in BALB/c Mice Im- 
munized with HEL.  We first explored the in vivo situation 
in BALB/c  mice immunized with HEL.  The experimental 
approach has been described in detail elsewhere (30). Briefly, 
RNA extracted  from a mixture of 5  x  106 to 5  x  107 LNC 
al~  was reverse transcribed into cDNA, and aliquots were amplified 
1.1  by PCR, using every one of the V~-specific oligonucleotide 
1.4  primers and one C/5-specific primer, The product of each PCR 
was then divided into 12 aliquots that were hybridized with 
1. s  a fluorescein-labeled oligonucleotide specific  for each of the 
1.5  12 known J~ segments.  A  run-off reaction was performed, 
1. s  and the sizes of the fluorescent run-off products were ana- 
l. 6  lyzed in an automated DNA sequencer.  In each run-off reac- 
tion, the polymerase transcribed the CDR3-1ike regions of 
2.1  various sizes, which were quantitatively recorded in the run- 
2.3  off products. For any given V~/-J~ combination, a set of about 
2.3  seven  size  classes,  spaced  by  three  nucleotides  and  corre- 
sponding to in-frame  transcripts,  was usually observed. 
2.3  A  sample of the actual graphical display is shown in Fig. 
2.3  3. The area under each peak is proportional to the number 
2.4  of  elongated  molecules  sharing  the  same  CDR3  length. 
1.3  Leaving out VB which  are deleted by MMTV  in BALB/c 
mice, there are 18 functional V~Ss (33). A complete analysis, 
2. s  therefore,  involves  18  x  12  =  216 run-off reactions,  each 
yielding an average of seven peaks of different  sizes, such that 
about 1,500 peaks are thus visualized. Each of these includes 
an  unknown  number  of  transcripts  (perhaps  dozens  or 
hundreds) sharing the same VB,  the same J~/, and the same 
CDR3  length,  but having distinct  CDR3  sequences. 
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Figure 3.  (,4) Profiles of  the 
fluorescent  V~8.2-JBs run-off  prod- 
ucts obtained with LNC of two 
nontransgenic mice. One was im- 
munized with  HEL in CFA and 
boosted 15 d later with HEL in IFA 
(--),  the  second one  (control) 
with  adjuvants only (----). LNC 
RNAs were extracted 9 d after the 
boost. The intensity of the fluores- 
cence is  represented in  arbitrary 
units as a function of the size  of the 
single-stranded DNA  fragments. 
RIS is presented between paren- 
theses next  to  a  few peaks￿9 (B) 
Profiles  of the fluorescent  V~8.2-J/~s 
run-off  products  obtained from 
HEbprimed LNC of nontransgenic 
mice No.  29, stimulated in vitro 
with HEL or peptide 103-117 (__) 
or from LNC of nontransgenic  mice 
immunized with CFA and stimu- 
lated in vitro with PPD as control 
(---). In A and B, the HEL and 
CFA profiles  were superimposed  and 
normalized with  respect to  the 
highest peak for each J~/. To have a clearer view, the control profiles (----) were slightly shifted to the right of those observed with run-off products 
from HEL-stimulated lymphocytes (__). 
We know from previous work (30) that the Gaussian-like 
distribution  of the peaks is highly reproducible and that  a 
significant perturbation of this distribution can be observed 
for specific combinations of VB, J~,  and CDR3  size, upon 
immunization with a protein antigen. Thus, the area of the 
peak corresponding to the antigen-specific TcR increases with 
respect to the other peaks arising from the same run-off reac- 
tion.  We previously defined a RIS which provides a quan- 
titative estimate of the increase over control (37, and Materials 
and Methods)￿9 
BALB/c mice were immunized with HEL in CFA (once 
or twice), BALB/c mice injected with CFA alone served as 
controls, and popliteal or inguinal LN RNAs were extracted 
and analyzed as described above. Because most of the hybrid- 
ST0  V~  Vw  CDR3  Fw  J~ 
95  96  9"/  98  99  i00  I01  102 
6  8.2  TGT GCC AGC  GGT GAT G~  AAC AAC CA(: ~  CCG  CTT TTT GGA  1.5 
C  A  S  G  D  f;  bl  N  Q  A  P  L  F  G 
7  8.2  TGT GCC AGC  GGT GAP ~  AAC AAC CAG GCT  CCG  CTT ~  GGA  1.5 
C  A  S  G  D  A  N  N  Q  A  P  L  F  G 
2 ￿9 3  8.2  T~T GCC AGC  GGG ACA G(2~ AAC AAC CAG GCT  CCG  CTT "FIT GGA  1.5 
C  A  S  G  T  G  N  N  Q  A  P  L  F  G 
Figure 4.  Nucleotide and deduced amino acid sequences of the junc- 
tional regions of the VB8.2-JB1.5 rearrangements found in LNC from 
nontransgenic mice immunized twice with HEL as described in Fig. 3. 
RNAs were prepared, reverse  transcribed, and the cDNAs were amplified 
with sense V~8.2 and antisense  J~1.5 primers. Amplified products were 
sequenced. The underlined nucleotide sequence  corresponds to the unam- 
biguously identified  D/~I sequence. These sequence  data are available  from 
EMBL/GenBank/DDBJ under accession number X79964-X79966. 
omas used the V~8,2 gene segment, we scanned VBS.2 run- 
off products combined with each JB segment. In Fig. 3 A, 
we show peaks from the same mouse immunized twice. A 
major alteration is seen in the VBS.2-J~l.5 combination, where 
a peak corresponding to a CDR3  size of eight amino acids 
emerges with a RIS of 3. The size of this CDR3 is precisely 
that found in the three independent T cell hybridomas specific 
for the HEL peptide 103-117 restricted by I-E  a and utilizing 
VBS.2 andJ~/1.5 segments, as described in Fig. 1. It is worth 
noting  that,  although  four hybridomas  shared V~8.2  and 
JB2.3, with CDR3 lengths of eight and nine amino acids, 
the corresponding peaks did not show a significant increase 
in RIS values in vivo. Nine individual mice were analyzed 
in this way, and the results were highly reproducible: every 
mouse displayed a major V~8.2-J~/1.5 peak (i.e., having the 
highest  RIS) with a CDR3  size of eight amino acids.  We 
sequenced three TcRs corresponding to peaks that displayed 
the highest RIS values (Fig. 4). One of them shares the amino 
acid CDR3  sequence with the C6.2 and M3.13 T  cell hy- 
bridomas. The other two differ by only one and two amino 
acids, respectively (D96 and A97). In summary,  the results 
indicate that an vivo T  cell response to lysozyme can be de- 
tected by our approach, and that it fitted, but only to a limited 
extent, the rearrangement found in our hybridoma collection. 
Extensive  Analysis  of TcR ,8 Chain  Transcripts in BALB/c 
Mice Immunized with HEL or Peptide 103-117.  We then fo- 
cused our analysis on the ID peptide 103-117 in the following 
way: mice were injected with 7 nmol of HEL in CFA, and 
9 d later, their LNC were recalled in vitro with 14 nmol of 
HEL or peptide 103-117 for 4 d, after which RNA was ex- 
tracted and analyzed as above. 10 individual mice were ana- 
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866  Public  and Private TCK Repertoires against Lysozyme lyzed for V38.2 and all J3s. In addition, four individual mice 
were analyzed for the 18 VBs (except V38.1,  which failed 
for technical reasons) and all J3s. 
A sample of the results is shown in Fig. 3 B. The predom- 
inant change in the V38.2-J31.5 major rearrangement is now 
more pronounced, with a RIS of 6.5  after in vitro recall. 
This confirmed our expectation that the response observed 
in vivo against HEL was indeed directed against the ID pep- 
tide 103-117. Again, this result was highly reproducible, and 
the major V38.2-J31.5 rearrangement with a CDR3 size of 
eight amino acids was observed in all 14 mice with RIS values 
ranging from 5 to  12. 
We then sequenced the V38.2-J31.5 PCR product in 12 
cases and obtained a readable sequence, proving the clonal 
character of the amplified product (Fig.  5 A).  11 of the 12 
sequences were identical to that of the C6.2 and M3.13 T 
cell hybridomas. The remaining one differed by a single,  si- 
lent nucleotide change. We ruled out the possibility that these 
sequences  could have originated from some contamination 
during the PCR because: (a) all sequences were not deter- 
mined simultaneously; (b) negative controls were added to 
each experiment showing that reagents were clean; (c) cDNAs 
from protein purified derivative (PPD)-stimulated LNC, when 
processed at the same time as cDNAs from 103-117 peptide- 
specific T cells, never showed such a dominant sequence; and 
(d) in all HEL-low transgenic mice tested, we never found 
this dominant rearrangement. 
The V38.2-J31.5 (CDR3 length  =  8) was not the only 
peak that emerged in BALB/c mice after immunization with 
HEL and in vitro recall with HEL or peptide 103-117. Given 
the high reproducibility of the Gaussian-like distribution of 
the peak sizes in this and other studies, we estimated that 
RIS values >4 are highly characteristic of the presence of a 
single expanded T cell clone. The data obtained with the four 
individual mice for which the entire repertoire was scanned, 
are summarized in Table 1, where all peaks displaying a RIS 
>4 have been indicated.  It can be seen that the number of 
these additional peaks varies from mouse to mouse in terms 
of V3 and J3 usage. Thus, when we compared the V3 reper- 
toires from individual nontransgenic animals,  we could not 
find any shared V3-J3 rearrangements other than the domi- 
nant V38.2-J31.5. 
Analysis  of HEL-Iow  Transgenic Mice.  Four  transgenic 
animals of the HEL-low type were analyzed in detail as above. 
A major rearrangement of the V38.2-J31.5  (CDR3 length 
=  8) type could not be detected in any of the mice. To confirm 
this, we sequenced the V38.2-JB1.5 PCR products and, in 
contrast to the nontransgenic situation, we could not obtain 
a readable sequence. We then searched for peaks with RIS 
values >4 in the other V3-J3 combinations. The results are 
summarized in Table 1. Peaks with high RIS show up in vari- 
able numbers and distinct combinations in individual mice. 
Two transgenic mice,  23  and 33,  preferentially use V38.3 
in association with different J3 segments, J31.4 and J31.5, 
respectively. The other two use a larger V3 repertoire. These 
minor V3-J3 combinations (found in mice Nos. 25 and 34, 
Table 1) are heterogeneous; eight different V3s are used be- 
tween the two mice with only one V3-J3 in common, V36- 
J32.7.  Among the V36-J3  combinations used,  none was 
similar to the two V/~6-J3 chains of HEL-specific T cell hy- 
bridomas  C5.4  and D12.8.  The rearrangements with  the 
highest RIS values found in each transgenic mouse were se- 
quenced. In some instances,  readable nucleotide CDR3 se- 
quences were obtained, and in-frame amino acid sequences 
were deduced as presented in Fig.  5 B. In three out of four 
sequences, we observed three conserved residues in the CDR3: 
G,  Q,  and N.  These amino  acids were found as GQN or 
GQQN motifs in different positions in CDR3  sequences. 
It is interesting to note that these CDR3 motifs are reminis- 
cent of the GNNQ sequence found in the CDR3 of the dom- 
inant V38.2-J~1.5 rearrangement of HEL-specific nontrans- 
genic T  cells. 
The T  cell V3 repertoires from transgenic and nontrans- 
genic mice showed that only a few V3-J3 were shared by 
both groups of mice: V31-J32.3  (mice Nos.  25 and 243), 
V34-J31.6 (mice Nos. 34 and 241),  and V313-J32.3 (mice 
Nos. 34 and 29). We could not compare the sequences from 
these rearrangements since only the CDR3 sequence of V31- 
J32.3 from mouse No. 25 was readable on a sequencing gel. 
It is striking that when the dominant rearrangement is not 
used, HEL-specific T cells from transgenic or nontransgenic 
animals express very different V3-J3 combinations. In HEL- 
low  transgenic  mice,  no  minor  rearrangement  becomes 
dominant. 
Figure 5.  (A) Nucleotide  and deduced  amino acid sequences  of  junctional regions of the dominant V38.2 D31J31.5 rearrangement  found  in different 
nontransgenic mice (Nos. 29-244) and BALB/c  mice (Nos. 1-5) and of minor rearrangements (V/~8.2-J31.4 and VB4-J31.5) found in BALB/c  mouse 
No. 3 and nontransgenic  No. 244, respectively.  Mice were immunized with HEL in CFA. 9 d later, the LNC were collected  and stimulated in vitro 
with HEL or peptide 103-117 for 4 d. LNC RNAs from both types of cultures were prepared and reverse  transcribed, cDNAs were amplified  with 
sense V/38.2 and antisense  J31.5 primers  and the amplified  products  were sequenced.  All nucleotide  sequences  of dominant rearrangements  were  identical 
except for mouse No. 46 where a G in the 4th codon was replaced  by a T. In this case, the D31 segment used is one codon shorter, the latter being 
replaced by the codon GGT from the V38.2 segment. The nucleotides of D31 origin are underlined (....) as are N diversity-encoded  nucleotides 
(__). (B) Nucleotide  and deduced amino acid sequences of major peaks found in HEL-specific  T lymphocytes  from individual HEL-low-transgenic 
mice. Underlined sequences correspond to D31 (--) or N diversity-encoded  nucleotides (__). These sequence  data are available from EMBL/Gen- 
Bank/DDBJ under accession number X79967-X79973. 
867  Cibotti  et al. Table  1.  Vfl-Jfls Rearrangements Observed in HEL-specific T Lymphocytes from  Nontransgenic and HEL-Iow Transgenic Mice 
Transgenics  Nontransgenic 
N ~  V/3  J3  CDR3 length  RIS  N ~  V3  J/3  CDR3 length  RIS 
23 
25 
8.3  1.4  11  8.5  29  1  2.1  11 
8.2  1.5  8 
1  2.3  9  6.9  13  1.2  8 
6  1.4  10  4.5  13  2.1  8 
6  1.4  11  4.2  13  2.2  10 
6  2.1  11  6.3  13  2.3  9 
6  2.7  8  5.3  16  1.2  10 
8.3  1.5  9  4.4 
12  1.2  7  4.2 
12  1.2  8  4.4  241  4  1.6  11 
4  2.4  11 
33  8.3  1.5  10  7.5  4  2.7  8 
8.3  2.2  10  4.7  8.2  1.5  8 
8.2  1.6  9 
34  4  1.6  11  4.2  15  1.5  9 
6  1.5  7  4.3 
6  2.7  7  4.8 
12  2.3  10  4.2 
13  2.3  8  4.1 
15  2.4  7  5.8 
4.9 
6.5 
4.3 
4.3 
4 
3.6 
4.3 
13 
6.6 
4.1 
9.6 
8 
5.6 
243  1  2.3  10  5.3 
8.2  1.5  8  10 
244  4  1.5  12  21 
8.2  1.4  9  9.9 
8.2  1.5  8  8.6 
Mice were immunized with HEL in CFA. 9 d later, the draining LN were collected and LNC were stimulated in vitro with HEL or peptide 103-117. 
After 4 d in culture, RNAs from 107 LNC were extracted and reverse  transcribed. After amplification  of the cDNA with the C/~ and 18 V3 primers, 
the run-off  reactions corresponding to each V3 were done with the 12 fluorescent  J3 primers. For each mouse, 216 combinations were tested. CDR3 
lengths are given for each peak that had a significant RIS value (RIS >4). The V33, V35, V311, and V317 were not tested since these VBs are 
deleted in BALB/c mice; the V38.1 primer was not used in these experiments. (Bold-face) Rearrangements that gave readable nucleotide sequences. 
Discussion 
We report here a detailed analysis of the T  cell response 
of BALB/c mice and HEL-low transgenic mice against the 
ID peptide 103-117 of HEL. The HEL-low transgenic mice 
are partially tolerant to HEL. In recent work, we have shown 
that  LNC  from  transgenic  mice  which  have  HEL blood 
levels <2  ng/ml  can be  recalled  in  vitro by HEL  and by 
the ID peptide 103-117 but not by the minimal ID peptide 
108-116  (29). 
We first determined the nucleotide sequences of the tran- 
scripts encoding the TcR 3  chains of 14 T  cell hybridomas 
directed against this dominant epitope. We then used a PCR.- 
based approach to analyze the distribution  of TcR 3  tran- 
scripts in LNC of BALB/c mice immunized with HEL, as 
well as in the LNC of BALB/c  mice and HEL-low trans- 
genic animals immunized once with HEL and recalled in vitro 
with HEL or the ID peptide 103-117. The TcR ot chains were 
not studied by our method for two reasons. First, the mul- 
tiplicity of Vot and Jot segments makes the analysis of ot chain 
transcripts  complex and  difficult.  Second,  it  is  now  well 
documented that T cells often display two in-phase ot chain 
transcripts,  which can obscure interpretations  (38). 
In the hybridoma collection,  12 out of 14 transcripts use 
the V38.2 gene segment. Among these, three use J31.5 and 
4 J~2.3. The V38.2-J~1.5 combination, with a CDR3 length 
of eight amino acids, emerged with a remarkable reproduci- 
bility in 9  out  of 9 BALB/c mice in vivo, as well as after 
in vitro recall of LNC from 14 animals out of 14. Nucleotide 
sequences showed perfect or nearly perfect identity with two 
of the hybridoma sequences, C6.2 and M3.13.  In contrast, 
the VB8.2-J32.3 combination with CDR3 lengths of eight 
or nine amino acids,  was undetected in vivo or upon recall 
in vitro. Most of the other combinations found in the hyo 
bridoma collection were also not detected, except for V38.2- 
JB1.4 which was found in one case in vitro. This rearrange- 
ment was sequenced and the deduced amino acid sequence 
was very close to that  of the Bl1.1  hybridoma which uses 
V38.2-J31.4  (Fig. 4).  Thus, as far as the dominance of the 
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cytochrome c [37])  the picture provided by the hybridoma 
collection is not a fully accurate reflection of the in vivo sit- 
uation. 
In LNC isolated from animals primed with HEL, the in 
vitro recall with an ID peptide tends to increase the sensi- 
tivity of detection of responsive T  cell clones, since higher 
ILlS for the VB8.2-J~l.5  combination are reproducibly ob- 
served with recalled LNC from nontransgenic animals. Thus, 
in all these animals that produce a highly VB-restricted re- 
sponse,  there appears to be a predominant way to recognize 
the ID peptide in the T  cell repertoire. It is worth noting 
that other combinations also emerge as peaks with elevated 
RIS, but, as summarized in Table 1, these peaks are different 
for each animal. In HEL-low transgenic animals, the domi- 
nant VBS.2-J~/1.5 combination could not be observed, but 
peaks with high RIS were detected. They were different from 
one transgenic animal to the other, and were different also 
from those found in nontransgenic mice. It is important to 
emphasize that: (a) these peaks are not found in CFA-treated 
controls; (b) they are detected over otherwise highly repro- 
ducible patterns (the Gaussian-like distribution which is con- 
sistently observed in our hands); and (c) several peaks could 
be sequenced and some display a GQQN motif highly reminis- 
cent of sequences found in the hybridoma collection. There- 
fore, these peaks cannot be the result of technical artefacts 
such as PCIL contaminations or statistical fluctuation of the 
size distribution. We conclude that they do in fact represent 
true T  cell responses to the ID peptide. 
Poindexter et al. (39) have compared the repertoire of  insulin- 
specific T cell hybridomas from normal and transgenic mice 
for human insulin. Their results showed that the V3 reper- 
toire of these T cell hybridomas is rather heterogeneous, with 
a predominant usage of V~I in normal mice. In transgenic 
mice, the V/~I chain was utilized in one out of 16 hybrid- 
omas, suggesting that human insulin-specific T lymphocytes 
bearing V~I TcR were deleted or anergized. Our findings 
are in agreement with such observations and extend the analysis 
by describing the full V/3 repertoire used by HEL-low trans- 
genic mice in response to a single, well-defined ID peptide. 
Our results can be summarized as follows. In BALB/c mice, 
the T lymphocytes that recognize in vitro the HEL ID pep- 
tide fall into two categories:  a dominant clone which emerges 
reproducibly in all animals, and a series of clones which vary 
in number and sequence in distinct animals. This phenomenon 
can be described by assuming that the T cell response to the 
ID HEL peptide in BALB/c mice includes two components: 
a public response that is identical in all animals and a private 
response that is specific to each individual. According to this 
terminology, the hybridoma collection displays both public 
and private specificities.  The public response is most likely 
directed against residues from the core determinant 108-116 
of the ID peptide.  The TciL(s) recognizing this core area 
presented by I-E  a have the highest affinities, whereas the pri- 
vate responses may focus on residues from the core deter- 
minant and additional residues on the longer peptide 103- 
117 or on additional residues only. In particular, one T cell 
hybridoma, G8.25, reacts strongly with peptide 103-117 but 
not with peptide 108-116, showing that at least some clones 
recognize a different epitope on the same peptide (29).  It is 
striking that the HEL-low transgenic mice display the pri- 
vate but not the public arm of the response. We propose, 
therefore, that the high affinity specific clones recognizing 
the 108-116 I-E  d complexes can be negatively selected in the 
presence of low levels of HEL. Thus, the high affinity V~8.2- 
J/~1.5 clones are eliminated or inactivated. In HEL-low trans- 
genic mice, residual proliferative responses are due to private 
clones which may have  a  lower affinity and/or  focus on 
different residues of the ID peptide (such as hybridoma G8.25). 
Do T cell responses,  in general, include a public and a pri- 
vate component? The available published data are scarce but 
they suggest that this may indeed be the case. In B10.A mice 
immunized with pigeon cytochrome c (PCC) and recalled 
in vitro by the same protein, the VB3-J/~I.2, V/33-J/32.5, and 
vB16-J31.2 TcR rearrangements have been frequently selected 
by the PCC peptide 81-104 restricted by I-E  k (13). Neverthe- 
less, only the V/~3-J31.2  and, to a lesser extent, the VB3- 
J32.5 rearrangement is observed in vivo (37). In an extensive 
study of the CTL response against the HLA-Cw3 peptide 
170-179  presented by K d in DBA/2  mice, the TcIL chains 
display very limited heterogeneity, both in terms of Vc~, Jc~ 
and V3, J3  segments in vitro.  The dominant V310-J31.2 
rearrangement observed in one out of two clones in vitro 
is always observed in vivo when mice are immunized with 
the HLA-Cw3 peptide (40). Similar observations were made 
by Levraud, J. P., C. Pannetier, P. Langlade-Demoyen, and 
P. Kourilsky (personal communication), who studied the V3 
repertoire of T  lymphocytes infiltrating P815 mastocytoma 
tumors. A  dominant V31-J31.2  rearrangement was found 
with a unique CDIL3 amino acid sequence. This sequence 
was also found in two out of five CTL clones specific for 
a peptide derived from the P815 tumor-specific antigen, PIA. 
The three other CTL clones display rearrangements not found 
in vivo.  Therefore, in three different experimental systems, 
a public response has been documented, but in all cases, hy- 
bridoma and/or clones with the same specificity contain rear- 
rangements and/or sequences that were not found in vivo, 
and could well correspond to private specificities. 
Is there any structural difference between public and pri- 
vate T cell clones? The dominant V38.2-J31.5  public rear- 
rangement involves no N additions, whereas most of the pri- 
vate rearrangements do (Fig. 2). This absence of N additions 
is reminiscent of fetal or neonatal combinations, and sug- 
gests that they might have occurred before the onset of ex- 
pression of terminal deoxynucleotidyl transferase.  However, 
this rearrangement cannot be considered as strictly germline 
since the V38.2, D31.1,  and J31.5 genomic segments have 
been trimmed. The absence of N additions cannot, however, 
be a general feature of dominant public rearrangements since, 
in the case of Thl response against PCC in B10.A mice (13, 
37), and of the CTL response against the HLA-Cw3 peptide 
presented by K a (40),  N  additions are found. On the other 
hand, the CDIL3 motif GQN or GQQN, shared by the pri- 
vate VB8.3-J31.4, VB8.3-J31.5, and V/815-J/32.4 rearrange- 
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in the public dominant V/38.2-J/31.5 rearrangement.  The pres- 
ence of these residues is particularly striking since they result 
from the rearrangements  of different VI3 and J13 segments 
selected by the  same peptide. 
How do the private T  cell clones originate,  and how do 
they escape tolerization  in the HEL-low transgenics?  Two 
different explanations could be proposed to account for this 
observation. One hypothesis would be that the high-avidity 
public and private clones have been tolerized,  whereas the 
private ones have been spared in these mice because of their 
low avidity. Thus, according to the TCR affinity model, the 
latter would be more difficult to tolerize than the former (for 
a review see reference 41), whereas the emergence of a low- 
avidity, private response might require additional steps, such 
as an elevated expression of adhesion molecules or coreceptors, 
which would favor cross-reactions. The choice of the private 
repertoire is likely to be influenced by the expansion of var- 
ious T  cell clones during ontogeny and prior experience in 
adult life. As an alternative possibility, the dominant public 
responses  seen here and in other experimental  models  (cf. 
above) could be explained by the existence of a powerful posi- 
tive selection process involving an as yet unknown selecting 
element. If private T cell clones may undergo positive selec- 
tion, it is interesting to consider that the positively selecting 
elements might themselves include public elements (displayed 
by all mice) and private ones (of a more random nature), thus 
yielding public and private T cell clones. The presence of public 
and private components in T  cell responses is reminiscent 
of the situation observed with antibodies, where responses 
with recurrent idiotypes are found together with a cortege 
of nonrecurrent ones (42), Furthermore, when structural genes 
controlling the expression of recurrent idiotypes in response 
to various  antigens were analyzed,  it was found that  each 
family of idiotype-positive antibodies was encoded by a limited 
number of VL genes and by one VH and JH gene segment 
(43-46). B lymphocytes bearing such dominant idiotypes dis- 
appear after neonatal  suppression with antiidiotypic antibodies. 
In the neonatally suppressed mice, B lymphocytes with al- 
ternative idiotypes are taking  over in response to the same 
antigen. Thus, although T and B cell repertoires are selected 
differently, clonal dominance is observed in both compart- 
ments and coexists with private distinct repertoires.  Such a 
finding may have important implications in autoimmune sit- 
uations where therapeutic attempts  to inactivate dominant 
autoreactive lymphocytes may fail, since new antiself clones 
may replace the initial autoreactive T  cells and exert poten- 
tially similar  pathogenic  effects. 
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